Literature DB >> 11673893

Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies.

Z Y Zhang1, B M King, Y N Wong.   

Abstract

A sensitive assay using high-performance liquid chromatography tandem mass spectrometry (MS/MS) has been established for the quantitative analysis of cytochrome P450 form-specific activities using warfarin as a probe substrate. Four metabolites, 6-, 7-, 8-, and 10-hydroxywarfarin, were chromatographically resolved within 10 min using gradient mobile phases. The mass spectrometry was operated under negative ionization mode. The MS/MS product ion spectra of warfarin and the metabolites were generated using collision-activated dissociation and interpreted. The abundant product ions of the metabolites were selected for quantification applying multiple reaction monitoring. Quantification was based on a quadratic or power curve of the peak area ratio of the metabolite over the internal standard against the respective concentration of the metabolite. This assay has been validated from 2 to 1000 nM for 10-hydroxywarfarin and from 2 to 5000 nM for 6-, 7-, and 8-hydroxywarfarin and successfully applied to evaluate cytochrome P450-mediated drug-drug interactions in vitro using human hepatocytes and liver microsomal preparations. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673893     DOI: 10.1006/abio.2001.5383

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  In silico pharmacogenetics of warfarin metabolism.

Authors:  Yingying Guo; Paul Weller; Erin Farrell; Paul Cheung; Bill Fitch; Douglas Clark; Shao-yong Wu; Jianmei Wang; Guochun Liao; Zhaomei Zhang; John Allard; Janet Cheng; Anh Nguyen; Sharon Jiang; Steve Shafer; Jonathan Usuka; Mohammad Masjedizadeh; Gary Peltz
Journal:  Nat Biotechnol       Date:  2006-05       Impact factor: 54.908

2.  A chiral HPLC-MS/MS method for simultaneous quantification of warfarin enantiomers and its major hydroxylation metabolites of CYP2C9 and CYP3A4 in human plasma.

Authors:  W Ju; K Peng; S Yang; H Sun; M Sampson; M Z Wang
Journal:  Austin J Anal Pharm Chem       Date:  2014

3.  Simultaneous Characterization and Determination of Warfarin and Its Hydroxylation Metabolites in Rat Plasma by Chiral Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Shasha Jin; Zhihong Li; Qing Yang; Boyu Fang; Xiaoqiang Xiang; Chao Peng; Weimin Cai
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

4.  Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.

Authors:  Xiaochun Wang; Jingguo Hou; Michael Jann; Yuen Yi Hon; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2012-11-26       Impact factor: 4.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.